Related Experiment Videos
Potential therapeutic usefulness of marijuana
Annual Review of Pharmacology and Toxicology
|January 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
Drug metabolism and disposition: the biological fate of chemicals·1997
The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
International clinical psychopharmacology·1993
Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
Clinical pharmacology and therapeutics·1992
Fluoxetine disposition and elimination in cirrhosis.
Clinical pharmacology and therapeutics·1988
The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.
Clinical pharmacology and therapeutics·1988
Making Drug Dosing Decisions Based on Therapeutic Monitoring.
Annual review of pharmacology and toxicology·2026
Pharmacoexposomics: The Environmental Complement to Pharmacogenomics to Advance Precision Medicine.
Annual review of pharmacology and toxicology·2026
Nonaddictive Analgesia: New Approaches That Target the Hodgkin-Huxley NaV/KV Dyad.
Annual review of pharmacology and toxicology·2026
Beyond Catalytic Inhibition: The Evolving Landscape of PARP Pharmacology.
Annual review of pharmacology and toxicology·2026
Vesicular Monoamine Transporters at the Crossroads of Structure and Function: Advances, Challenges, and Future Perspectives.
Annual review of pharmacology and toxicology·2026
The Pharmacology of CAR T Cell Therapy for Autoimmune Disease.
Annual review of pharmacology and toxicology·2026
SiaRNA: a siamese neural network with bidirectional cross-attention for pairwise siRNA-mRNA efficacy prediction.
Frontiers in bioinformatics·2026
Beyond Antioxidant Activity: Redox-Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera.
Journal of experimental pharmacology·2026
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders.
ACS medicinal chemistry letters·2026